EUDA Valuation

EUDA Health Holdings Ltd

Add to Watchlist

Advanced Chart

2.600

+0.168(6.908%)1D

Overview
Forecast
Valuation
Earnings

EUDA Relative Valuation

EUDA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EUDA is overvalued; if below, it's undervalued.

Historical Valuation

EUDA Health Holdings Ltd (EUDA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 6.23 is considered Undervalued compared with the five-year average of -17.85. The fair price of EUDA Health Holdings Ltd (EUDA) is between 4.41 to 8.29 according to relative valuation methord. Compared to the current price of 2.55 USD , EUDA Health Holdings Ltd is Undervalued By 42.14%.

Relative Value

Fair Zone

4.41-8.29

Current Price：2.55

42.14%

Undervalued

-22.11

Trailing

Forward

0.00

EV/EBITDA

EUDA Health Holdings Ltd. (EUDA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -4.63. The thresholds are as follows: Strongly Undervalued below -16.10, Undervalued between -16.10 and -10.36, Fairly Valued between 1.10 and -10.36, Overvalued between 1.10 and 6.84, and Strongly Overvalued above 6.84. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-775.58

EV/EBIT

EUDA Health Holdings Ltd. (EUDA) has a current EV/EBIT of -775.58. The 5-year average EV/EBIT is -62.23. The thresholds are as follows: Strongly Undervalued below -480.92, Undervalued between -480.92 and -271.58, Fairly Valued between 147.12 and -271.58, Overvalued between 147.12 and 356.47, and Strongly Overvalued above 356.47. The current Forward EV/EBIT of -775.58 falls within the Strongly Undervalued range.

5.04

EUDA Health Holdings Ltd. (EUDA) has a current PS of 5.04. The 5-year average PS is 7.46. The thresholds are as follows: Strongly Undervalued below -4.39, Undervalued between -4.39 and 1.54, Fairly Valued between 13.39 and 1.54, Overvalued between 13.39 and 19.31, and Strongly Overvalued above 19.31. The current Forward PS of 5.04 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

EUDA Health Holdings Ltd. (EUDA) has a current P/OCF of 0.00. The 5-year average P/OCF is -5.18. The thresholds are as follows: Strongly Undervalued below -18.57, Undervalued between -18.57 and -11.87, Fairly Valued between 1.52 and -11.87, Overvalued between 1.52 and 8.22, and Strongly Overvalued above 8.22. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

EUDA Health Holdings Ltd. (EUDA) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

EUDA Health Holdings Ltd (EUDA) has a current Price-to-Book (P/B) ratio of -29.98. Compared to its 3-year average P/B ratio of -14.87 , the current P/B ratio is approximately 101.58% higher. Relative to its 5-year average P/B ratio of -11.51, the current P/B ratio is about 160.35% higher. EUDA Health Holdings Ltd (EUDA) has a Forward Free Cash Flow (FCF) yield of approximately -2.49%. Compared to its 3-year average FCF yield of -3.77%, the current FCF yield is approximately -33.92% lower. Relative to its 5-year average FCF yield of -3.80% , the current FCF yield is about -34.56% lower.

-35.39

P/B

Median3y

-14.87

Median5y

-11.51

-2.78

FCF Yield

Median3y

-3.77

Median5y

-3.80

Competitors Valuation Multiple

The average P/S ratio for EUDA's competitors is 44.17, providing a benchmark for relative valuation. EUDA Health Holdings Ltd Corp (EUDA) exhibits a P/S ratio of 5.04, which is -88.60% above the industry average. Given its robust revenue growth of -95.71%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

EUDA.O

EUDA Health Holdings Ltd

Burning Rock Biotech Ltd

Radiopharm Theranostics Ltd

Performance Decomposition

Market capitalization of EUDA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of EUDA in the past 1 year is driven by Unknown.